GlycoMimetics
(NASDAQ:GLYC)
$1.6504
-0.0596[-3.49%]
At close: Apr 26
$1.6504
0[0.00%]
After Hours: 7:34PM EDT
Q1 2024 Earnings in 11 days from now on Thu May 9th, before the market open

GlycoMimetics Stock (NASDAQ:GLYC), Insider Trading Activity

GlycoMimetics: Insider buying and selling updated today.

Insider Shares Owned
2.159M
Insider Percentage Owned
3.35%
Institutional Shares Held
7.022M
Institutional Percentage Held
10.9%
Filing Date
Insider Names
Insider Title
Qty.
Price
Size ($)
Type
Δ Own
Own
Trade Dates
SEC Filing
Sep 25, 2023Edwin RockCHIEF MEDICAL OFFICER65.403K$1.38$90.26KBUY21.10%375.403KSep 21 - Sep 22View
May 18, 2023Brian HahnSVP FINANCE, CFO-3.7K$1.95-$7.21KSELL-6.51%53.143KMay 17View
May 11, 2023DANIEL JUNIUSDIRECTOR30K$1.56$46.80KBUY47.43%93.25KMay 10View
May 09, 2023Bruce JohnsonSVP & CHIEF COMMERCIAL OFFICER13.5K$1.57$21.20KBUY10.76%138.98KMay 08View
Feb 28, 2023Invus Public Equities LPArtal International SCAArtal International Management SASA Group ArtalSA WestendAmaury WittouckWestend Administratiekantoor StichtingInvus Public Equities Advisors LLC10% OWNER100K$1.70$170.00KBUY1.18%8.589064MFeb 24View
Feb 23, 2023Invus Public Equities LPArtal International SCAArtal International Management SASA Group ArtalSA WestendAmaury WittouckWestend Administratiekantoor StichtingInvus Public Equities Advisors LLC10% OWNER400K$1.78$712.25KBUY4.94%8.489064MFeb 21 - Feb 23View
Feb 17, 2023Invus Public Equities LPArtal International SCAArtal International Management SASA Group ArtalSA WestendAmaury WittouckWestend Administratiekantoor StichtingInvus Public Equities Advisors LLC10% OWNER1.515266M$2.00$3.03MBUY23.05%8.089064MFeb 15 - Feb 17View
Feb 13, 2023Invus Public Equities LPArtal International SCAArtal International Management SASA Group ArtalSA WestendAmaury WittouckWestend Administratiekantoor StichtingInvus Public Equities Advisors LLC10% OWNER11.451K$3.24$37.12KBUY0.17%6.573798MFeb 09View
Jan 27, 2023SCOTT SANDELL10% OWNER-3.652016M$3.14-$11.48MSELL-62.01%2.237196MJan 25 - Jan 26View
Jan 06, 2023SCOTT SANDELL10% OWNER-71.362K$2.76-$196.86KSELL-1.81%3.881933MJan 05View
Jan 04, 2023SCOTT SANDELL10% OWNER-398.133K$2.98-$1.19MSELL-9.23%3.914072MDec 30 - Jan 04View
Dec 27, 2022Edwin RockCHIEF MEDICAL OFFICER110K$2.25$247.50KBUY55.00%310KDec 22View
Nov 18, 2022DANIEL JUNIUSDIRECTOR20K$1.87$37.40KBUY46.24%63.25KNov 17View
Nov 16, 2022Edwin RockCHIEF MEDICAL OFFICER200K$1.54$309.00KBUY200KNov 14 - Nov 15View
Nov 14, 2022TIMOTHY PEARSONDIRECTOR19.4K$1.29$25.03KBUY369.52%24.65KNov 11View
Nov 14, 2022Harout SemerjianCHIEF EXECUTIVE OFFICER25K$1.29$32.25KBUY25KNov 11View
Nov 14, 2022Brian HahnSVP FINANCE, CFO20K$1.06$21.20KBUY54.28%56.843KNov 11View
Nov 14, 2022John MagnaniSVP RESEARCH, CSO45.045K$1.17$52.70KBUY13.82%370.923KNov 11View
Nov 14, 2022Armand GirardSVP, CHIEF BUSINESS OFFICER6.5K$1.05$6.83KBUY28.68%29.161KNov 11View

FAQ

Q

Is Insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch